Literature DB >> 35596832

Nuclear receptor Nr1d1 alleviates asthma by abating GATA3 gene expression and Th2 cell differentiation.

Drishti Tiwari1, Nancy Ahuja2, Sumit Kumar2, Rashi Kalra2,3, Ravikanth Nanduri2,4, Shalini Gupta2, Asheesh Kumar Khare2, Ella Bhagyaraj2,5, Rashmi Arora2, Pawan Gupta6.   

Abstract

Nuclear receptors are a unique family of transcription factors that play cardinal roles in physiology and plethora of human diseases. The adopted orphan nuclear receptor Nr1d1 is a constitutive transcriptional repressor known to modulate several biological processes. In this study, we found that Nr1d1 plays a decisive role in T helper (Th)-cell polarization and transcriptionally impedes the formation of Th2 cells by directly binding to the promoter region of GATA binding protein 3 (GATA3) gene. Nr1d1 interacts with its cellular companion, the nuclear receptor corepressor and histone deacetylase 3 to form a stable repression complex on the GATA3 promoter. The presence of Nr1d1 also imparts protection against associated inflammatory responses in murine model of asthma and its ligand SR9011 eased disease severity by suppressing Th2 responses. Moreover, Chip-seq profiling uncovered Nr1d1 interactions with other gene subsets that impedes Th2-linked pathways and regulates metabolism, immunity and brain functions, therefore, providing empirical evidence regarding the genetic link between asthma and other comorbid conditions. Thus, Nr1d1 emerges as a molecular switch that could be targeted to subdue asthma.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Asthma; GATA3; Nuclear receptor; T lymphocytes; T-bet

Mesh:

Substances:

Year:  2022        PMID: 35596832     DOI: 10.1007/s00018-022-04323-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  90 in total

Review 1.  Nuclear hormone receptors: Roles of xenobiotic detoxification and sterol homeostasis in healthy aging.

Authors:  Julia Marianne Hoffmann; Linda Partridge
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-09-18       Impact factor: 8.250

Review 2.  Asthma-related comorbidities.

Authors:  Louis-Philippe Boulet; Marie-Ève Boulay
Journal:  Expert Rev Respir Med       Date:  2011-06       Impact factor: 3.772

Review 3.  The orphan nuclear receptors in cancer and diabetes.

Authors:  Harmit S Ranhotra
Journal:  J Recept Signal Transduct Res       Date:  2013-03-25       Impact factor: 2.092

Review 4.  Cytokine/anti-cytokine therapy - novel treatments for asthma?

Authors:  Philip M Hansbro; Gerard E Kaiko; Paul S Foster
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 5.  The many paths to asthma: phenotype shaped by innate and adaptive immunity.

Authors:  Hye Young Kim; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Immunol       Date:  2010-06-18       Impact factor: 25.606

Review 6.  Allergic asthma: influence of genetic and environmental factors.

Authors:  Anil B Mukherjee; Zhongjian Zhang
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

7.  Asthma control and disease burden in patients with asthma and allergic comorbidities.

Authors:  Lulu K Lee; Engels Obi; Brandee Paknis; Abhishek Kavati; Bradley Chipps
Journal:  J Asthma       Date:  2017-06-06       Impact factor: 2.515

8.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

Review 9.  T cell-mediated host immune defenses in the lung.

Authors:  Kong Chen; Jay K Kolls
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

Review 10.  Economic burden of asthma: a systematic review.

Authors:  Katayoun Bahadori; Mary M Doyle-Waters; Carlo Marra; Larry Lynd; Kadria Alasaly; John Swiston; J Mark FitzGerald
Journal:  BMC Pulm Med       Date:  2009-05-19       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.